NRX Pharmaceuticals, Inc. Annual Weighted Average Number of Shares Outstanding, Diluted from 2020 to 2022

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
NRX Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2020 to 2022.
  • NRX Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending March 31, 2024 was 8.85M shares, a 33.2% increase year-over-year.
  • NRX Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 65.8M shares, a 40.2% increase from 2021.
  • NRX Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2021 was 46.9M shares, a 36.9% increase from 2020.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 65.8M +18.8M +40.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-31
2021 46.9M +12.6M +36.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-31
2020 34.3M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.